openPR Logo
Press release

Quick Update & Your E-Ticket for Ophthalmic Drugs 2017

08-14-2017 10:54 AM CET | Health & Medicine

Press release from: SMi Group

View Complete Agenda

View Complete Agenda

Ophthalmic Drugs has gained some great traction throughout these few months, with an incredible representation from our pharma industry experts, who will help you tackle every possible obstacle you may face through real-life case studies. Gain insight into current trends in novel technology being used for preclinical and clinical trials.

Companies Attending: Santen Inc., Shire, Novartis, Roche, NightstaRx, Aerie Pharmaceuticals, Bayer, Envisia Therapeutics, Boehringer Ingelheim, Oxford BioMedica, Novaliq GmbH, Alimera Sciences, Aptar Pharma and PharmaMedic Consultancy Ltd.

Presenting Case Studies & Topics Within: Novel approaches to the treatment of ocular diseases such as presbyopia and glaucoma, combating challenges in drug release and delivery, regulatory considerations involving new technologies and patient reported outcomes.

The finalised agenda is now available online: www.ophthalmicdrugs.com/prl

How Can You Benefit?

- 16+ Peer-led Sessions
- 15+ Hrs of Highly Interactive Content
- An Audience of Ophthalmic Experts & Innovators Under 1 Roof

Learn. Tackle. Network.

Claim e-ticket online, and save £300 (limited time only) www.ophthalmicdrugs.com/opr

Check out the finalised agenda here: www.ophthalmicdrugs.com/opr

SMi is Proud to Present the Launch of…
Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: London, UK
Website: www.ophthalmicdrugs.com/opr

Sponsors:

- EXPERIMENTICA
- LEICA MICROSYSTEMS

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminster Bridge Rd, London SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Quick Update & Your E-Ticket for Ophthalmic Drugs 2017 here

News-ID: 667540 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for View

Investigation announced for Long-Term Investors in shares of View, Inc. (NASDAQ: …
An investigation was announced over possible breaches of fiduciary duties by certain directors of View, Inc.. Investors who are current long term investors in View, Inc. (NASDAQ: VIEW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: VIEW stocks follows a lawsuit filed against View, Inc. over alleged securities
Deadline on October 18th coming up for Investors in shares of View, Inc. (NASDAQ …
A deadline is coming up on October 18, 2021 in the lawsuit filed for certain investors of View, Inc. (NASDAQ: VIEW) over alleged securities laws violations by View, Inc. Investors who purchased shares of View, Inc. (NASDAQ: VIEW) have certain options and there are strict and short deadlines running. Deadline: October 18, 2021. NASDAQ: VIEW stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Instant Payments: A Global View
Researchmoz added Most up-to-date research on "Instant Payments: A Global View" to its huge collection of research reports. An insight on the important factors and trends influencing the market. "Instant Payments: A Global View", report contains an in-depth review of instant payment systems around the world, including analysis of the key systems currently in place, and their strengths and weaknesses. Instant payment systems are becoming increasingly prevalent worldwide, as central banks and
The American view of Russia
US media play an important role in the rekindled debates about cultural values and national identities as between America and Russia. – A battle waged on the back of minorities, as demonstrated by a current research project supported by the Austrian Science Fund FWF. Is homosexuality forbidden in Russia? If one does not know for sure one would probably guess the answer is "yes". The image of a country under
liquidFOLDERS now with timeline view
liquidFOLDERS, an innovative Windows file manager made in Germany, is available for download in a new version 1.2 on the company's website (www.liquidfolders.net/download/). The most prominent addition is a timeline view (picture) that displays all local files chronologically. This is especially useful for browsing pictures. In addition, the new version delivers some minor improvements, and is even more user-friendly than previous releases. "Our team is working on a whole bunch of new
WRS Italia: an international view
Nowadays themes related to the energy saving and recycling are relevant and significant topics to be considered to respect and protect the environment. Government, corporate and enterprises, key players in the countries’ economies, have a pivotal role in the environment safeguard and objectification of these purposes. Thus, these aims can be realized through the development of innovative systems and machines to involve companies to recycle and preserve the environment. Hence, WRS